Replay available

Schrodinger, Inc. (SDGR) Q3 2025 Earnings Call

Schrodinger, Inc. (NASDAQ: SDGR) Q3 2025 earnings conference call, held 2025-11-05. Replay captured from the company's public earnings webcast.

Wed, November 5, 2025 at 4:30 PMendedReplay
Schrodinger, Inc. (SDGR) Q3 2025 Earnings Call

Hosted by

Featured presenters

Jaron Madden

Chief Corporate Affairs Officer and Head of Investor Relations

Rami Fareed

Chief Executive Officer

Richie Jain

Chief Financial Officer

Karen Akinsanya

President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships

Manny Frohart

Analyst, Learing Partners

Scott Schoenhals

Analyst, KeyBank Capital Markets

Matt Hewitt

Analyst, Craig Howland Capital Group

Dennis Ding

Analyst, Jefferies

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Schrodinger, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.694 and I'll be your operator for today's call. 00:00:02.694 -- 00:00:05.917 All lines have been placed on mute to prevent any background noise. 00:00:05.917 -- 00:00:09.121 After the speaker's remarks, there will be a question and answer session. 00:00:09.121 -- 00:00:12.725 If you'd like to ask a question during this time, simply press star then the number one 00:00:12.725 -- 00:00:17.350 on your telephone keypad. Please be advised that this call is being recorded at the company's 00:00:17.350 -- 00:00:21.374 request. Now I would like to introduce your host for today's conference, Ms. 00:00:21.374 -- 00:00:25.438 Jaron Madden, Chief Corporate Affairs Officer and Head of Investor Relations. 00:00:25.438 -- 00:00:27.841 Please go ahead. 00:00:27.841 -- 00:00:32.142 Thank you and good afternoon, everyone. Welcome to today's call, during which we will 00:00:32.142 -- 00:00:36.849 provide an update on the company and review our third quarter 2025 financial results. 00:00:36.849 -- 00:00:40.554 Earlier today, we issued a press release summarizing our financial results and progress 00:00:40.554 -- 00:00:44.980 across the company, which is available on our website at schrodinger.com. 00:00:44.980 -- 00:00:49.627 Here with me on our call today are Rami Fareed, Chief Executive Officer, Richie Jain, 00:00:49.627 -- 00:00:54.734 Chief Financial Officer, and Karen Akinsanya, President, Head of Therapeutics R&D 00:00:54.734 -- 00:00:59.224 and Chief Strategy Officer, Partnerships. Following our prepared remarks, we'll open 00:00:59.224 -- 00:01:03.859 the call for Q&A. During today's call, management will make statements that are forward-looking 00:01:03.859 -- 00:01:07.672 and made pursuant to the safe harbor provisions of the Private Securities ...